Earnings Call · Q4 FY2022·2023-02-23

Q4 22EPS +20.75%·Rev n/aQ3 22EPS +0.72%·Rev n/aQ2 22EPS +1.37%·Rev n/aQ1 22EPS +2.25%·Rev n/a⚠ consensus missing

IMMUNIC, INC. IMUX

Jessica Breu — Head of Investor Relations and Communications

Daniel Vitt — Chief Executive Officer and President

Glenn Whaley — Chief Financial Officer

+4.2%1d on move date+3.7% vs SPY3d0.0%5d+4.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IMUX calls or request research access.

More IMUX calls Browse calls Request research access